Literature DB >> 3987767

Serum digoxin concentrations in a representative digoxin-consuming adult population.

O Impivaara, E Iisalo.   

Abstract

As part of health examination of a representative sample of an adult population (n = 8000) serum digoxin concentration was measured in 661 patients on continuous digoxin therapy. The prescribed mean daily dose of digoxin was significantly higher in men (223 micrograms) than in women (201 micrograms); the dose significantly decreased with increasing age. The mean serum digoxin concentration was the same in men and women and it differed insignificantly between age groups, although older persons tended to have a higher concentration. The age - adjusted mean steady state digoxin concentration was 1.02 ng/ml in men and 0.98 ng/ml in women; in about 60% the concentration was within the "therapeutic" range (0.80-2.00 ng/ml). The concentrations were clearly related to daily dose of digoxin. At equal dose levels old persons tended to have higher concentrations than younger persons. The interindividual variation in serum digoxin concentrations was very wide. However, when digoxin measurements in the same subjects were repeated about three months later, a good correlation between the two measurements was found. The interval between the last dose of digoxin and the collection of blood (up to 41 h) had relatively little effect on individual serum digoxin concentrations. Patients on concomitant thiazide or loop diuretic therapy had the same mean serum digoxin concentration as those not-receiving a diuretic. The mean concentration was significantly higher in patients taking a thiazide or loop diuretic combined with triamterene. The difference may have been due to an interaction between triamterene and digoxin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987767     DOI: 10.1007/bf00547039

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Serum levels and renal excretion of digoxin in the elderly. A comparison between three different preparations.

Authors:  E Iisalo; I Ruikka
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

2.  [Digoxin treatment in general practice].

Authors:  E Iisalo; E Schrey
Journal:  Duodecim       Date:  1977

Review 3.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

4.  Use of digitalis in general practice. Liverpool Therapeutics Group.

Authors: 
Journal:  Br Med J       Date:  1978-09-02

5.  Serum digoxin determination in outpatients--need for standardization.

Authors:  T Jogestrand; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

6.  Amiloride-induced changes in digoxin dynamics and kinetics: abolition of digoxin-induced inotropism with amiloride.

Authors:  S Waldorff; P B Hansen; H Kjaergård; J Buch; H Egeblad; E Steiness
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Digitalis therapy in a 70-year-old population.

Authors:  S Landahl; B Lindblad; S Roupe; B Steen; A Svanborg
Journal:  Acta Med Scand       Date:  1977

8.  Digoxin compliance in patients from general practice.

Authors:  G D Johnston; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

9.  Digoxin-prescribing. Mostly good news.

Authors:  M Weintraub; F E Karch; J P Morgan; N Trabert; A Sorensen; L A Becker; L Lasagna
Journal:  JAMA       Date:  1979-08-03       Impact factor: 56.272

10.  Spironolactone-induced changes in digoxin kinetics.

Authors:  S Waldorff; J D Andersen; N Heebøll-Nielsen; O G Nielsen; E Moltke; U Sørensen; E Steiness
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

View more
  1 in total

1.  Prescription monitoring of drug dosages in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985.

Authors:  A Wessling; G Boëthius; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.